Treatable ApS: Financial statements 2023
CVR: 41152613
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Treatable ApS (CVR 41152613) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -640,714 and a net result of DKK -640,833 compared with DKK -57,197 the year before. Equity in the 2023 report amounted to DKK -1,049,247.
- Gross Profit
- DKK -640,714
- Profit/Loss
- DKK -640,833
- Equity
- DKK -1,049,247
- Total Assets
- DKK 751,730
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -641 t. | -641 t. | -1 mio. | - |
| 2022 | 63 t. | 191 t. | -57 t. | -408 t. | - |
| 2021 | - | -248 t. | -252 t. | -351 t. | 0 |
| 2020 | - | -136 t. | -140 t. | -100 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Treatable ApS has published its annual report for 2022. Revenue came to DKK 62,712, and the net result was DKK -57,197.
About Treatable ApS
Treatable ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2020. The company is registered under the industry Fysio- og ergoterapi. The company was previously named Academy ApS and Pamels ApS. The management consists of Nicolas Mateo Soham Rockland. The company is owned by Rockland ApS. According to the 2024 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -6,415 and a net result of DKK 2,782 compared with DKK 1,289,636 the year before. Equity in the 2025 report amounted to DKK 243,170.